Reviewing once more the c-myc and Ras collaboration: Converging at the cyclin D1-CDK4 complex and challenging basic concepts of cancer biology

Chenguang Wang, Michael P. Lisanti, D. Joshua Liao

Research output: Contribution to journalReview articlepeer-review

85 Scopus citations

Abstract

The c-myc is a proto-oncogene that manifests aberrant expression at high frequencies in most types of human cancer. C-myc gene amplifications are often observed in various cancers as well. Ample studies have also proved that c-myc has a potent oncogenicity, which can be further enhanced by collaborations with other oncogenes such as Bcl-2 and activated Ras. Studies on the collaborations of c-myc with Ras or other genes in oncogenicity have established several basic concepts and have disclosed their underlying mechanisms of tumor biology, including "immortalization" and "transformation". In many cases, these collaborations may converge at the cyclin D1-CDK4 complex. In the mean-time, however, many results from studies on the c-myc, Ras and cyclin D1-CDK4 also challenge these basic concepts of tumor biology and suggest to us that the immortalized status of cells should be emphasized. Stricter criteria and definitions for a malignantly transformed status and a benign status of cells in culture also need to be established to facilitate our study of the mechanisms for tumor formation and to better link up in vitro data with animal results and eventually with human cancer pathology.

Original languageEnglish (US)
Pages (from-to)57-67
Number of pages11
JournalCell Cycle
Volume10
Issue number1
DOIs
StatePublished - Jan 1 2011

Bibliographical note

Funding Information:
We would like to thank Dr. Fred Bogott at the Medical Center of Austin of Minnesota, for his excellent English editing of the manuscript. This work was supported by a NIH grant (RO1CA100864) to D.J. Liao.

Keywords

  • Cyclin D1
  • Immortalization
  • Oncogene
  • Transformation
  • c-Myc

Fingerprint Dive into the research topics of 'Reviewing once more the c-myc and Ras collaboration: Converging at the cyclin D1-CDK4 complex and challenging basic concepts of cancer biology'. Together they form a unique fingerprint.

Cite this